Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection.
Eur Rev Med Pharmacol Sci
; 25(9): 3607-3609, 2021 May.
Article
in English
| MEDLINE | ID: covidwho-1232732
ABSTRACT
Severe Acute Respiratory Syndrome Corona Virus-2 is the causative factor of Coronavirus Disease 2019. Early in the pandemic, mediastinal lymphadenopathy was not considered to be a significant radiologic finding of the SARS-COV-2 disease. Nevertheless, most recent studies associate mediastinal lymphadenopathy with more severe COVID-19 disease and poorer patient outcomes.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Lymphadenopathy
/
SARS-CoV-2
/
COVID-19
/
Mediastinal Diseases
Type of study:
Diagnostic study
/
Observational study
Limits:
Humans
Language:
English
Journal:
Eur Rev Med Pharmacol Sci
Journal subject:
Pharmacology
/
Toxicology
Year:
2021
Document Type:
Article
Affiliation country:
Eurrev_202105_25843
Similar
MEDLINE
...
LILACS
LIS